Our research
Developing novel regenerative medicine therapies to improve human health.
Research within Liverpool’s Regenerative Medicine Network falls into five main categories:
-
The goal of this group is to develop cellular and molecular based regenerative medicine therapies that can treat patients in the early stages of kidney disease and help prevent them from developing life threatening end stage kidney disease.
-
The long term goal of this group is to develop more sensitive and specific methods to detect changes in chronic and acute liver disease earlier and to develop cellular and molecular-based regenerative medicine therapies.
-
The aim of this group is to develop and support regenerative and reconstructive therapies from the basic science in our laboratories to patients within the clinics in St Paul’s Eye Unit, to tackle the debilitating diseases that underlie vision loss and blindness.
-
Researchers study two gut areas: the intestinal epithelium, seeking therapies to speed repair after IBD damage, and the enteric nervous system, developing treatments for Hirschsprung's disease.
-
The aim of this group is to better understand the molecular mechanisms causing tissue degeneration in the musculoskeletal system and to use stem cells and tissue engineering to reconstruct damaged tissue, alleviate pain and improve quality of life.